Literature DB >> 2240367

Recombinant capsular antigen (fraction 1) from Yersinia pestis induces a protective antibody response in BALB/c mice.

W J Simpson1, R E Thomas, T G Schwan.   

Abstract

Yersinia pestis produces a glycoprotein capsule, the biosynthesis of which appears to be temperature dependent. The fraction I (F1) component of this capsule is specific to Y. pestis and the detection of F1 antibodies is the basis for several serological tests. We report the cloning of the F1 gene and its expression in Escherichia coli using the phagemid vector lambda ZAPII and a F1-specific monoclonal antibody. The recombinant F1 antigen had a molecular weight of 17 kDa, which proved to be identical to that of the F1 antigen produced by Y. pestis. The recombinant cells produced F1 antigen at 37 degrees C but only minimal amounts at 27 degrees C, suggesting that the genetic features affected by temperature in Y. pestis may be operating in the E. coli clone. It is not known if their similar molecular weights reflect the glycosylated nature of both proteins. F1 antigen purified from the E. coli recombinant induced a protective immune response in BALB/c mice challenged with up to 10(5) virulent Y. pestis. The resistance of immunized mice to plague infection correlated with high titers of F1 antibody. The cloned gene expresses an immunogenically competent F1 antigen suitable for use in plague serodiagnostics and vaccine development.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2240367     DOI: 10.4269/ajtmh.1990.43.389

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  24 in total

1.  Proteomic characterization of Yersinia pestis virulence.

Authors:  Brett A Chromy; Megan W Choi; Gloria A Murphy; Arlene D Gonzales; Chris H Corzett; Brian C Chang; J Patrick Fitch; Sandra L McCutchen-Maloney
Journal:  J Bacteriol       Date:  2005-12       Impact factor: 3.490

Review 2.  Interaction between Yersinia pestis and the host immune system.

Authors:  Bei Li; Ruifu Yang
Journal:  Infect Immun       Date:  2008-02-04       Impact factor: 3.441

3.  Effect of Yersinia pestis YopM on experimental plague.

Authors:  J Nemeth; S C Straley
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

4.  Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge.

Authors:  G P Andrews; D G Heath; G W Anderson; S L Welkos; A M Friedlander
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

5.  LcrV delivered via type III secretion system of live attenuated Yersinia pseudotuberculosis enhances immunogenicity against pneumonic plague.

Authors:  Wei Sun; Shilpa Sanapala; Jeremy C Henderson; Shandiin Sam; Joseph Olinzock; M Stephen Trent; Roy Curtiss
Journal:  Infect Immun       Date:  2014-08-11       Impact factor: 3.441

6.  Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis.

Authors:  Anna N Honko; Nammalwar Sriranganathan; Cynthia J Lees; Steven B Mizel
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

7.  Conjugation of Y. pestis F1-antigen to gold nanoparticles improves immunogenicity.

Authors:  A E Gregory; E D Williamson; J L Prior; W A Butcher; I J Thompson; A M Shaw; R W Titball
Journal:  Vaccine       Date:  2012-09-18       Impact factor: 3.641

8.  Effective protective immunity to Yersinia pestis infection conferred by DNA vaccine coding for derivatives of the F1 capsular antigen.

Authors:  Haim Grosfeld; Sara Cohen; Tamar Bino; Yehuda Flashner; Raphael Ber; Emanuelle Mamroud; Chanoch Kronman; Avigdor Shafferman; Baruch Velan
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

9.  Oral vaccination against bubonic plague using a live avirulent Yersinia pseudotuberculosis strain.

Authors:  Thierry Blisnick; Patrick Ave; Michel Huerre; Elisabeth Carniel; Christian E Demeure
Journal:  Infect Immun       Date:  2008-05-27       Impact factor: 3.441

10.  Effective plague vaccination via oral delivery of plant cells expressing F1-V antigens in chloroplasts.

Authors:  Philip A Arlen; Michael Singleton; Jeffrey J Adamovicz; Yi Ding; Abdolreza Davoodi-Semiromi; Henry Daniell
Journal:  Infect Immun       Date:  2008-05-27       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.